Approval · Notice of Compliance 33793 · 2024
LEDAGA: Notice of Compliance 33793
Issued August 9, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33793
- Date
- August 9, 2024
- Company
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production . Change in the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEDAGA | Not yet assigned | — |
Medicinal ingredients
- CHLORMETHINE HYDROCHLORIDE 160 MCG per G